CSIMarket Company Name, Ticker, Suppliers, else..
 
Metsera Inc   (NASDAQ: MTSR)
 
Price: $70.5000 $-0.25 -0.353%
Day's High: $70.78 Week Perf: -15.24 %
Day's Low: $ 70.13 30 Day Perf: 33.57 %
Volume (M): 27,908,900 52 Wk High: $ 83.86
Volume (M$): $ 1,967,577 52 Wk Avg: $60.38
Open: $70.74 52 Wk Low: $51.83



 Market Capitalization (Millions $) 7,405
 Shares Outstanding (Millions) 105
 Employees -
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -314
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Business Description


Metsera, Inc. is a clinical-stage biotechnology company engaged in the development of product candidates through preclinical studies and clinical trials. The company utilizes its platforms and peptide library to discover and develop therapies. It has not yet commercialized any products and has incurred significant operating losses.


   Company Address: 3 World Trade Center New York 10007 NY
   Company Phone Number: 784-6595   Stock Exchange / Ticker: NASDAQ MTSR


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Business Update

Green Light for Growth Pfizer Clears Regulatory Hurdle in Strategic Metsera Acquisition,

Published Mon, Nov 3 2025 9:48 AM UTC

Pfizer s Strategic Acquisition of Metsera Receives Green Light from U.S. Federal Trade Commission Pfizer Inc. (NYSE: PFE) is poised to expand its pharmaceutical portfolio following the U.S. Federal Trade Commission’s (FTC) decision to grant early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act). This decision clears...
Clinical Study

Metsera Unveils Groundbreaking Obesity Therapies at EASD 2025 A New Era in Metabolic Disease Management,

Published Thu, Sep 11 2025 11:23 AM UTC

In a significant development poised to influence the landscape of obesity and metabolic disease treatment, Metsera, Inc. (Nasdaq: MTSR) is set to present its pioneering research at the 61st Annual Meeting of the European Association for the Study of Diabetes (EASD). The event, scheduled to take place from September 15-19, 2025, in Vienna, Austria, will serve as a platform fo...
Shares

Metsera, Inc. Launches Initial Public Offering Priced at $18.00 Per Share, Set to Revolutionize Obesity Treatment Market

Published Thu, Jan 30 2025 11:53 PM UTC

Metsera, Inc. Launches Initial Public Offering Priced at $18.00 Per Share, Set to Revolutionize Obesity Treatment MarketOn January 30, 2025, Metsera, Inc. (Nasdaq: MTSR), a clinical-stage biotechnology company specializing in the development of next-generation injectable and oral nutrient-stimulated hormone (NuSH) analog peptides for obesity and related conditions, announced...
Shares

Metseras Successful IPO: A New Dawn for Innovative Biotechnology in Obesity Treatment

Published Wed, Feb 5 2025 9:02 PM UTC

Outline of Facts:1. Company Overview: - Metsera, Inc. is a clinical-stage biotechnology company focused on developing next-generation injectable and oral nutrient-stimulated hormone (NuSH) analog peptides aimed at treating obesity, overweight issues, and related conditions.2. Initial Public Offering (IPO): - The IPO involved the sale of 15,277,778 shares of common stock,...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book 21.96
PEG (TTM) -

Financial Strength Current
Quick Ratio 4.13
Working Capital Ratio 4.25
Leverage Ratio (MRQ) 0.68
Total Debt to Equity 0.01
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -6.46 $
Revenues (TTM) -
Cash Flow (TTM) -
Cash 4.27 $
Book Value 3.21 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) -
Net Income per Employee (TTM) -
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) -

Profitability Ratios Current
Gross Margin (MRQ) -
Operating Margin (MRQ) -
Net Margin (MRQ) -
Net Cash Flow Margin (MRQ) -
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.